Gene · 60485
Papers1,483
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,483
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Extracellular matrix stiffness activates mechanosensitive signals but limits breast cancer cell spheroid proliferation and invasion. | Front Cell Dev Biol | 2023 | 38125873 | PubTator, text mining | PubMed |
| The involvement of E3 ubiquitin ligases in the development and progression of colorectal cancer. | Cell Death Discov | 2023 | 38104139 | PubTator, text mining | PubMed |
| YAP-mediated trophoblast dysfunction: the common pathway underlying pregnancy complications. | Cell Commun Signal | 2023 | 38098027 | PubTator, text mining | PubMed |
| Regulatory mechanism of macrophage polarization based on Hippo pathway. | Front Immunol | 2023 | 38090595 | PubTator, text mining | PubMed |
| New Insights into YAP/TAZ-TEAD-Mediated Gene Regulation and Biological Processes in Cancer. | Cancers (Basel) | 2023 | 38067201 | PubTator, text mining | PubMed |
| YY1 modulates the radiosensitivity of esophageal squamous cell carcinoma through KIF3B-mediated Hippo signaling pathway. | Cell Death Dis | 2023 | 38065955 | PubTator, text mining | PubMed |
| Oncofetal reprogramming in tumor development and progression: novel insights into cancer therapy. | MedComm (2020) | 2023 | 38045829 | PubTator, text mining | PubMed |
| TGF-β/SMAD canonical pathway induces the expression of transcriptional cofactor TAZ in liver cancer cells. | Heliyon | 2023 | 38027697 | PubTator, text mining | PubMed |
| Organotypic 3D Cell-Architecture Impacts the Expression Pattern of miRNAs-mRNAs Network in Breast Cancer SKBR3 Cells. | Noncoding RNA | 2023 | 37987362 | PubTator, text mining | PubMed |
| Insights into the mechanism of SARS-CoV-2 main protease autocatalytic maturation from model precursors. | Commun Biol | 2023 | 37957287 | PubTator, text mining | PubMed |
| Signaling pathways and targeted therapeutic strategies for polycystic ovary syndrome. | Front Endocrinol (Lausanne) | 2023 | 37929034 | PubTator, text mining | PubMed |
| The Hippo pathway in endometrial cancer: a potential therapeutic target? | Front Oncol | 2023 | 37927473 | PubTator, text mining | PubMed |
| MST2 methylation by PRMT5 inhibits Hippo signaling and promotes pancreatic cancer progression. | EMBO J | 2023 | 37905571 | PubTator, text mining | PubMed |
| Methyl Canthin-6-one-2-carboxylate Restrains the Migration/Invasion Properties of Fibroblast-like Synoviocytes by Suppressing the Hippo/YAP Signaling Pathway. | Pharmaceuticals (Basel) | 2023 | 37895911 | PubTator, text mining | PubMed |
| Nuclear Import and Export of YAP and TAZ. | Cancers (Basel) | 2023 | 37894323 | PubTator, text mining | PubMed |
| Hippo Pathway Knockdown Gene Therapy in the Heart. | Tex Heart Inst J | 2023 | 37859620 | PubTator, text mining | PubMed |
| SPTAN1/NUMB axis senses cell density to restrain cell growth and oncogenesis through Hippo signaling. | J Clin Invest | 2023 | 37843276 | PubTator, text mining | PubMed |
| ASCARIS: Positional feature annotation and protein structure-based representation of single amino acid variations. | Comput Struct Biotechnol J | 2023 | 37822561 | PubTator, text mining | PubMed |
| PDIVAS: Pathogenicity predictor for Deep-Intronic Variants causing Aberrant Splicing. | BMC Genomics | 2023 | 37817060 | PubTator, text mining | PubMed |
| Transcriptomics of mussel transmissible cancer MtrBTN2 suggests accumulation of multiple cancer traits and oncogenic pathways shared among bilaterians. | Open Biol | 2023 | 37816387 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/60485/papers?page=5